<DOC>
	<DOCNO>NCT00132860</DOCNO>
	<brief_summary>The purpose study investigate , ﻿ patient moderate severe chronic obstructive lung disease , whether intermittent antibiotic treatment lead : - A slow rate decline force expiratory volume one second ( FEV1 ) ; - A reduction frequency severity exacerbation ; - Fewer hospital admission chronic obstructive pulmonary disease ( COPD ) ; - Lower mortality ; - An improved quality life compare group placebo treat patient .</brief_summary>
	<brief_title>Prophylactic ﻿Antibiotic Treatment Patients With Chronic Obstructive Lung Disease ( COLD )</brief_title>
	<detailed_description>﻿Study Population : Patients moderate severe chronic obstructive lung disease . Trial Phase : IV Study Design : Prospective , randomised , double-blind , placebo- control clinical trial . Study Medicine : Azithromycin . Drug Administration : Oral . Drug Dose : 500 mg daily 3 day every month . Duration Treatment : 3 year Number Evaluable Patients : 200 per treatment arm Number Included Patients : 400 per treatment arm , 800 patient total .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Patients 50 year age , current admission exacerbation COLD least one admission within previous two year . Current exsmoker Postbronchodilator FEV1 &lt; 60 % stable condition ( &gt; 4 week hospitalisation ) &lt; 300 ml bronchodilator reversibility FEV1 Patients endstage COLD , expect survive 3 year ( typically bedridden patient dyspnoeic rest ) . Patients known respiratory tract infection , e.g . tuberculosis aspergillosis , intervention know inefficient . Patients pulmonary malignancy Patients pulmonary disease COLD . Patients immunodeficiency . However , COLD patient treat steroid include . Patients know hereditary disposition lung infection alfa1antitrypsin deficiency , cystic fibrosis primary ciliary dyskinesia . Patients receive longterm antibiotic treatment ( e.g . recurrent cystitis ) . Patients know allergy intolerance azithromycin Pregnant breastfeed woman Manifest heart , liver renal insufficiency Patients , reason state , unlikely able participate study period 3 year .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
</DOC>